ArticleBMC geriatrics2025
Acceptability and usability of continuous glucose monitoring systems in older adults aged 75 years and older with diabetes.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThe purpose of this study is to explore the acceptability and usability of continuous glucose monitoring (CGM) systems as experienced by older adults aged 75 years and older with diabetes.
methodsUsing a qualitative research design, data were collected through semi-structured interviews with 14 older adults aged 75 years and older with diabetes who had no prior experience with CGM, following two weeks of CGM use. Transcripts were analyzed using a thematic qualitative analysis method to identify key statements related to participants' experiences with CGM, with a focus on acceptability and usability.
resultsCGM was generally perceived as acceptable and useful by participants. Four key themes emerged from the analysis: Device-related burdens, barriers to CGM use, duality of CGM impact, and reflection and empowerment, along with 9 sub-themes. While CGM significantly enhanced glucose management awareness and promoted healthier lifestyle changes, it also induced psychological stress due to constant monitoring. Participants noted several barriers such as the inconvenience of carrying and charging a mobile device, complex device operations, and difficulties using educational materials due to visual impairments. The high cost of the CGM device was seen as a substantial economic barrier, underscoring the necessity for financial interventions like broader insurance coverage for individuals with type 2 diabetes.
conclusionThis study suggests that CGM may improve health outcomes for older adults aged 75 years and older with diabetes by enhancing both its acceptability and usability. It highlights the need for comprehensive technical, educational, and financial support to facilitate effective CGM usage in older adults aged 75 years and older with diabetes. Recommendations to improve usage include the adoption of wearable devices or dedicated receivers, extended battery life, user-friendly interfaces with larger fonts and clearer visual presentations, and enhanced insurance coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.